President Donald Trump nominated Landon Heid, who served on the staff of the House of Representatives' Select Committee on ...

President Donald Trump plans to nominate Landon Heid, who served on the staff of the House of Representatives' Select ...

Having kicked off the year with a T-cell engager deal, AbbVie has returned to the modality. | Having kicked off the year with ...

Tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.

WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop ...

In the current global market landscape, volatility has been a significant theme, with U.S. stocks experiencing fluctuations due to competitive pressures in the tech sector and ongoing geopolitical ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

AstraZeneca has been approached a couple of times by Chinese authorities about their investigation into the drugmaker's ...

The BioSecure Act seeks to reduce US-China biotech ties, creating potential for India to become a biomanufacturing hub.

A PAT roadmap should address data analysis, aggregation, visualization, and the smart utility of those data for greater process understanding.